LAKE OSWEGO, Ore.--()--BIOTRONIK, Inc., announced today the U.S. launch of its new Reocor external pacemaker. The device is available in two models, for dual- and single-chamber pacing therapy, and offers individualized patient therapy, easy handling and flexibility in every detail. Reocor enriches BIOTRONIK’s portfolio of high quality cardiovascular devices and sets a new standard of quality for external pacing therapy.
“Reocor has an intuitive design to simplify its utility. Clearly marked dials display selectable parameter values. The dials are simple and customers have told us that they’re perfect for visualizing programmed settings with just a quick glance,” commented Rex Richmond, Vice President of Marketing, BIOTRONIK, Inc. “As a result, the device is easy to use without extensive training.”
The new device also features an extended longevity that increases reliability and reduces costs over time. Extended battery service times of up to 600 hours for permanent pacing therapy (with the Reocor S model), supplemented with a backup power supply during battery replacement, ensures easy handling and longer continuous usage in daily practice.
Reocor, which effectively delivers individual solutions for a broad range of patients, accommodates high pacing outputs and high pacing rates—a capability that is especially important when caring for pediatric patients.
Reocor is the latest in a series of advanced new devices BIOTRONIK has launched during the past two years. In 2011, the company introduced advanced external devices into the market that include a new pacing system analyzer and a new programmer system—demonstrating its commitment to develop the highest quality, most complete CRM product portfolio in the industry.
“BIOTRONIK’s Reocor offers our customers clear ease of use advantages. It is an external pacemaker that combines superior longevity and convenient handling all in a compact and durable form factor,” said Jake Langer, President of BIOTRONIK, Inc. “This device is another example of BIOTRONIK’s commitment to quality.”
About BIOTRONIK SE & Co. KG
As one of the world’s leading manufacturers of cardiovascular medical devices, with several million devices implanted, BIOTRONIK is represented in over 100 countries by its global workforce of more than 5,600 employees. Known for having its finger on the pulse of the medical community, BIOTRONIK assesses the challenges physicians face and provides the best solutions for all phases of patient care, ranging from diagnosis to treatment to patient management. Quality, innovation and reliability define BIOTRONIK and its growing success—and deliver confidence and peace of mind to physicians and their patients worldwide.
More information: www.biotronik.com
Upon publication, please provide us with a copy.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50274591&lang=en
